Roivant Sciences Ltd. (ROIV) Misses Q2 EPS by 4c

Roivant Sciences Ltd. (NASDAQ: ROIV) reported Q2 EPS of ($0.42), $0.04 worse than the analyst estimate of ($0.38). Revenue for the quarter came in at $12.53 million versus the consensus estimate of $5.7 million.

For earnings history and earnings-related data on Roivant Sciences Ltd. (ROIV) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• Robinhood prices $2B convertible notes offering due 2029
• Worried the AI trade has gone too far? Evercore likes these 4 stocks